丹古伊尼安通可以通过调节PI3k/AKT信号通路来减轻突纤维化
Qing Liao1, Shuang Wu2, Xiao Li2
1Traditional Chinese Pharmacological Laboratory, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510000, China.
Journal of ethnopharmacology
|January 20, 2025
概括
丹古伊宁通 (Danggui Niantong Decoction,DGNTD) 通过减少炎症标志物和调节PI3K/AKT通路来缓解骨关节炎疼痛和纤维化. 这种传统中医药为骨关节炎管理提供了一个新的治疗途径.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 骨关节炎研究 骨关节炎研究
背景情况:
- 丹古伊宁通 (Danggui Niantong Decoction,简称DGNTD) 是一种用于治疗类风湿性关节炎和骨关节炎 (OA) 的传统中医配方.
- 甲状腺综合体的特征是炎症,纤维细胞样同胞细胞 (FLS) 增殖和纤维化,导致疼痛和硬.
- 在OA synovium中DGNTD的确切机制尚不清楚.
研究的目的:
- 为了阐明DGNTD对OA synovium的影响.
- 研究DGNTD在OA中的作用的潜在分子机制.
主要方法:
- 液态染色体质谱法 (LC-MS) 确定了DGNTD成分.
- 鼠类FLS和OA动物模型 (ACLT/MMx) 用于评估DGNTD对突炎和纤维化的影响.
- 进行了蛋白质组学和基因表达分析 (mRNA).
主要成果:
- 在DGNTD中,LC-MS检测到322个组件.
- 在体内研究表明,DGNTD减少了OA疼痛,突炎症和纤维化,降低了CGRP,iNOS,α-SMA和Col3a1.3等标志物.
- 在TGF-β诱导的FLS中,DGNTD抑制了亲炎性和纤维性基因表达,涉及PI3K/AKT通路.
结论:
- 通过调节PI3K/AKT信号通路,DGNTD可以部分缓解OA疼痛,肌炎和纤维化.
- 这些发现为OA机制和DGNTD的治疗潜力提供了见解.
- 为使用DGNTD在OA临床管理中提供了理论和实验基础.
更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.7K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
493
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
